Register
TRANSFORM LDL-C risk, a new study to identify high-risk patients with established ASCVD |
Clinical News
eMediNexus Coverage from: 
TRANSFORM LDL-C risk, a new study to identify high-risk patients with established ASCVD
eMediNexus,  18 April 2019
remove_red_eye 499 Views
#Cardiology #Pathology and Lab Medicine #Public Health

0 Read Comments                

The American College of Cardiology has joined hands with Sanofi and Regeneron to conduct a new national study - TRANSFORM LDL-C Risk - to identify high-risk patients with atherosclerotic cardiovascular disease (ASCVD) and optimizing their access to the latest evidence-based treatments for low-density lipoprotein cholesterol (LDL-C) lowering and cardiovascular event risk reduction.
To continue reading this article
Sign in with Medtalks

Continue reading your article with a eMediNexus account.
Free Membership!